Switzerland

February 2021 Edition

Interviews
Anne Lévy
director-general, FOPH

As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for public health in Switzerland; developing the country’s health policy and working to create an efficient and affordable healthcare system in the long term.

René P Buholzer
CEO, Interpharma, Switzerland

Interpharma’s Dr René P. Buholzer highlights the key lessons that Switzerland’s innovative pharmaceutical industry has taken from the COVID-19 pandemic, the challenges inherent in the country’s two upcoming cost contain…

Anne Lévy
director-general, FOPH

As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for public health in Switzerland; developing the country’s health policy and working to create an efficient and affordable healthcare system in the long term.

René P Buholzer
CEO, Interpharma, Switzerland

Interpharma’s Dr René P. Buholzer highlights the key lessons that Switzerland’s innovative pharmaceutical industry has taken from the COVID-19 pandemic, the challenges inherent in the country’s two upcoming cost contain…

Henrik Asmussen
General Manager, Amgen Switzerland

In a wide-ranging interview, Henrik Asmussen outlines his priorities for Amgen’s important Swiss affiliate, market access and pricing challenges, the company’s exciting pipeline, and what makes Amgen Switzerland a…

Thomas Bohn
Executive Director, Greater Geneva Bern area (GGBa), Switzerland

Thomas Bohn outlines how the life sciences industry in Western Switzerland has continued to perform well despite the COVID-19 pandemic, highlights some of the key re…

Henrik Asmussen
General Manager, Amgen Switzerland

In a wide-ranging interview, Henrik Asmussen outlines his priorities for Amgen’s important Swiss affiliate, market access and pricing challenges, the company’s exciting pipeline, and what makes Amgen Switzerland a…

Thomas Bohn
Executive Director, Greater Geneva Bern area (GGBa), Switzerland

Thomas Bohn outlines how the life sciences industry in Western Switzerland has continued to perform well despite the COVID-19 pandemic, highlights some of the key re…

Read the Full Version
Pierre Morneau
General Manager, Takeda Switzerland

Pierrre Morneau of Takeda Switzerland explains the therapeutic areas at the core of the company, equitable access, the Swiss framework for rare diseases, and the major challenges he is dealing with…

Urs Vögeli
Managing Director, Janssen Switzerland

Urs Vögeli, managing director for Janssen Switzerland, outlines the importance of the Swiss operations to Janssen, his interesting career journey, Janssen’s commitment to bringing transformational medical…

Axel Steiger
CEO, Bayer Switzerland

Axel Steiger, CEO and CFO for Bayer Switzerland, outlines the importance of the Swiss operations as one of the key global hubs for Bayer, his leadership and talent management philosophy, the investment and commitment Bayer is making…

Pierre Morneau
General Manager, Takeda Switzerland

Pierrre Morneau of Takeda Switzerland explains the therapeutic areas at the core of the company, equitable access, the Swiss framework for rare diseases, and the major challenges he is dealing with…

Urs Vögeli
Managing Director, Janssen Switzerland

Urs Vögeli, managing director for Janssen Switzerland, outlines the importance of the Swiss operations to Janssen, his interesting career journey, Janssen’s commitment to bringing transformational medical…

Axel Steiger
CEO, Bayer Switzerland

Axel Steiger, CEO and CFO for Bayer Switzerland, outlines the importance of the Swiss operations as one of the key global hubs for Bayer, his leadership and talent management philosophy, the investment and commitment Bayer is making…

Katharina Gasser
Managing Director, Biogen Switzerland

Biogen Switzerland’s Dr med Katharina Gasser outlines how her affiliate navigated the COVID-19 pandemic from an organisational and communication perspective, the increasing importance being given…

Vincent Gruntz
General Manager Oncology, Novartis Pharma Switzerland

Vincent Gruntz looks at the market dynamics for oncology in Switzerland, where an increasingly cost-conscious approach is being taken to reimbursement and pricing, his…

Jean-Paul Clozel
CEO, Idorsia

In an exclusive interview, Jean-Paul Clozel explains Idorsia’s unique value proposition as a biotech focused on small molecules, how agnosticism in terms of therapeutic areas leads to more innovative medical breakthroughs, and why scientifi…

Katharina Gasser
Managing Director, Biogen Switzerland

Biogen Switzerland’s Dr med Katharina Gasser outlines how her affiliate navigated the COVID-19 pandemic from an organisational and communication perspective, the increasing importance being given…

Vincent Gruntz
General Manager Oncology, Novartis Pharma Switzerland

Vincent Gruntz looks at the market dynamics for oncology in Switzerland, where an increasingly cost-conscious approach is being taken to reimbursement and pricing, his…

Jean-Paul Clozel
CEO, Idorsia

In an exclusive interview, Jean-Paul Clozel explains Idorsia’s unique value proposition as a biotech focused on small molecules, how agnosticism in terms of therapeutic areas leads to more innovative medical breakthroughs, and why scientifi…

Annalise Eggimann
CEO, Innosuisse

Innosuisse CEO Annalise Eggimann presents the organisation’s renewed mandate as the main Swiss innovation promotion agency, how Innosuisse serves Switzerland’s vast array of SMEs, and why the country needs to guard against complacency to stay…

Jan Tangermann
Country Head, Sandoz Switzerland

Sandoz Switzerland’s Jan Tangermann highlights the importance of the Swiss affiliate to the global group and how it was able to provide sustainable and reliable access to critical and essential medicines duri…

Chris Martin
CEO, Co-Founder and Director, ADC Therapeutics

Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC Therapeutics, shares the company’s journey over the past de…

Annalise Eggimann
CEO, Innosuisse

Innosuisse CEO Annalise Eggimann presents the organisation’s renewed mandate as the main Swiss innovation promotion agency, how Innosuisse serves Switzerland’s vast array of SMEs, and why the country needs to guard against complacency to stay…

Jan Tangermann
Country Head, Sandoz Switzerland

Sandoz Switzerland’s Jan Tangermann highlights the importance of the Swiss affiliate to the global group and how it was able to provide sustainable and reliable access to critical and essential medicines duri…

Chris Martin
CEO, Co-Founder and Director, ADC Therapeutics

Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC Therapeutics, shares the company’s journey over the past de…

Marcel Platiner
President, vips

Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as well as the continuing attractiveness of Switzerland as a pharmaceutical investment destination.

Sabine Bruckner
Country Manager, Pfizer Switzerland

Pfizer Switzerland’s Sabine Bruckner discusses Switzerland’s historic and continuing importance to Pfizer, vaccine development and uptake, and the significant benefits of building a diverse leadership team.

Michael Quirmbach
CEO and president, CordenPharma

The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing industry, explaining the reasons behind the recent commercial success of his organization, includin…

Marcel Platiner
President, vips

Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as well as the continuing attractiveness of Switzerland as a pharmaceutical investment destination.

Sabine Bruckner
Country Manager, Pfizer Switzerland

Pfizer Switzerland’s Sabine Bruckner discusses Switzerland’s historic and continuing importance to Pfizer, vaccine development and uptake, and the significant benefits of building a diverse leadership team.

Michael Quirmbach
CEO and president, CordenPharma

The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing industry, explaining the reasons behind the recent commercial success of his organization, includin…

Jon Helsdingen
General manager, AbbVie

AbbVie Switzerland’s Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office move, the acquisition and integration of Allergan and the COVID-19 pandemic in a single year. Helsding…

Mads Stoustrup
Vice president and general manager, Novo Nordisk

Novo Nordisk Switzerland’s Mads Stoustrup introduces the affiliate’s remarkable process on bringing innovative diabetes and obesity treatments to market in the past four…

Stephan Mumenthaler
Director General, scienceindustries, Switzerland

scienceindustries’ Stephan Mumenthaler outlines the business-friendly regulation necessary to…

Jon Helsdingen
General manager, AbbVie

AbbVie Switzerland’s Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office move, the acquisition and integration of Allergan and the COVID-19 pandemic in a single year. Helsding…

Mads Stoustrup
Vice president and general manager, Novo Nordisk

Novo Nordisk Switzerland’s Mads Stoustrup introduces the affiliate’s remarkable process on bringing innovative diabetes and obesity treatments to market in the past four…

Stephan Mumenthaler
Director General, scienceindustries, Switzerland

scienceindustries’ Stephan Mumenthaler outlines the business-friendly regulation necessary to…

Tytus Litynski
General Manager Switzerland & Member of Board of Directors, Alfasigma

Alfasigma Switzerland’s Dr Tytus Litynski introduces the Italian firm’s diversified portfolio of both Rx drugs and food supplements in Switzerlan…

Axel Müller
Managing director, Intergenerika

Intergenerika’s Dr Axel B. Müller makes an impassioned case against the introduction of a reference pricing system in Switzerland, arguing that it would hurt not only the Swiss generics industry but, ultimately, patients. Dr…

Anil Okay
General manager, Adalvo; chief commercial officer, Alvotech

CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio approach…

Tytus Litynski
General Manager Switzerland & Member of Board of Directors, Alfasigma

Alfasigma Switzerland’s Dr Tytus Litynski introduces the Italian firm’s diversified portfolio of both Rx drugs and food supplements in Switzerlan…

Axel Müller
Managing director, Intergenerika

Intergenerika’s Dr Axel B. Müller makes an impassioned case against the introduction of a reference pricing system in Switzerland, arguing that it would hurt not only the Swiss generics industry but, ultimately, patients. Dr…

Anil Okay
General manager, Adalvo; chief commercial officer, Alvotech

CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio approach…

Martin Naville
CEO, Swiss-American Chamber of Commerce

In a wide-ranging conversation, Martin Naville of AmCham Switzerland looks at the evolution of the Switzerland-US trade relationship and the importance of pharma within it, the pressing need for a free trade agreement between…

Pius Zängerle
Director, curafutura, Switzerland

Pius Zängerle of curafutura, one of the two largest Swiss health insurers’ associations, explains the unique Swiss health insurance ecosystem and the main issues on his agenda for 2021 beyond the global pandemic…

Susan M. Gasser
Director Emeritus & Group Leader, Friedrich Miescher Institute for Biomedical Research (FMI), Switzerland

Professor Susan M. Gasser, now director and group leader emeritus…

Martin Naville
CEO, Swiss-American Chamber of Commerce

In a wide-ranging conversation, Martin Naville of AmCham Switzerland looks at the evolution of the Switzerland-US trade relationship and the importance of pharma within it, the pressing need for a free trade agreement between…

Pius Zängerle
Director, curafutura, Switzerland

Pius Zängerle of curafutura, one of the two largest Swiss health insurers’ associations, explains the unique Swiss health insurance ecosystem and the main issues on his agenda for 2021 beyond the global pandemic…

Susan M. Gasser
Director Emeritus & Group Leader, Friedrich Miescher Institute for Biomedical Research (FMI), Switzerland

Professor Susan M. Gasser, now director and group leader emeritus…

Thanks for reading!

The Digital Version of the Healthcare & Life Sciences Review: Switzerland is available and optimized for desktop browsers.

Visit our website with your computer or download the pdf report

Read the Full Version

2021. Healthcare & Life Sciences Review was produced by Pharmaboardroom.

Copyright: All rights reserved. No part of this publication maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this report, neither PharmaBoardroom nor the authors accept any liabilities forerrors and omissions. Opinions expressed in this report are not necessarily those of the authors. All the images belongs to its respective authors.

Report Director: Carla Verdera
Senior Editor: Patrick Burton, Louis Haynes
Publisher: Diana Viola
Graphic Designer: Miriam León

PharmaBoardroom

Contact us

+44 20 7867 3717 info@pharmaboardroom.com

For media inquiries, please contact: media@pharmaboardroom.com

Address

PharmaBoardroom Limited Lynton House, 7-12, Tavistock Square, London, United Kingdom, WC1H 9LT

Subscribe